A B S T R A C T Butanol-insoluble iodinated compounds in the urine of patients with congenital goiters have been generally regarded as iodopeptides. Monoiodohistidine (MIH) and diiodohistidine (DIH) were identified from the urine of four patients with congenital goitrous hypothyroidism. From radioiodine studies, 40-70% of the urinary radioactivity was in the iodide-free fraction from which about 40% was identified as MIH and DIH by crystallizations to a constant specific activity.
A B S T R A C T Butanol-insoluble iodinated compounds in the urine of patients with congenital goiters have been generally regarded as iodopeptides. Monoiodohistidine (MIH) and diiodohistidine (DIH) were identified from the urine of four patients with congenital goitrous hypothyroidism. From radioiodine studies, 40-70% of the urinary radioactivity was in the iodide-free fraction from which about 40% was identified as MIH and DIH by crystallizations to a constant specific activity.
Iodotyrosines were simultaneously identified in the urine. However the presence of an iodotyrosine-deiodinase activity was demonstrated in the two removed goiters with a normal Km for MIT. In vivo iodotyrosine deiodination was normal for hypothyroid subjects.
No thyroglobulin was identified in the thyroids from these patients. The major iodoprotein was iodoalbumin which, after in vivo labeling, contained 84-89% of the total soluble protein radioactivity. The thyroxine content of the goiter iodoalbumins and other iodoproteins was extremely low.
Iodohistidines were identified in comparable proportions in the iodoalbumin and in the other iodoproteins isolated from each goiter. The average iodohistidine content of these proteins as crystallizable MIH and DIH was in the individual cases 15 and 4% of the in vivo incorporated radioiodine. DIH was identified in all iodoprotein fractions. The mean DIH/MIH ratios from the individual cases were 1.16 and 0.35. The corresponding DIT/MIT ratios were 3.19 and 1.45, respectively.
The major consequence of this thyroglobulin defect is the iodination of inappropriate proteins (mainly albumin) resulting in low yields of thyroxine and high
INTRODUCTION
The discovery of "peptide-linked iodotyrosines and iodothyronines" in the blood of a congenital goitrous hypothyroid patient led to the description of the "syndrome of congenital goiter with butanol-insoluble serum iodine" (1, 2) . The circulating iodo-compound was identified, at least in part, as iodoalbumin (3) (4) (5) . An iodoalbumin has been identified in similar goiters (6) , and thyroglobulin has been reported as reduced (3) (4) (5) 7) or apparently absent (2, (8) (9) (10) (11) . From similar patients, other butanol-insoluble compounds were detected either in thyroid (2, 4, 7) or serum (1, 4, 8) hydrolysates, and in urines (2, 3, 10, 11) . These compounds, constituting the butanol-insoluble iodine (BII)' moiety of the urine, were not identified. In general, the assumption was made that they were iodopeptides and that their presence in urine indicated defective iodoprotein breakdown. In an effort to identify these compounds from the BII fraction 1 Abbreviations used in this paper: BII, butanol-insoluble iodine; PBI, protein-bound iodine; MIH, 4-monoiodo-Lhistidine; DIH, ?,4-diiodo-L-histidine; MIT, 3-monoiodo-Ltyrosine; DIT, 3;5-diiodo-L-tyrosine; T4, 3,5,3',5'-tetraiodo-L-thyronine; Ts, 3,5,3'-triiodo-L-thyronine; Tg, thyroglobulin; RISA, radioiodinated human serum albumin; Ta, thyralbumin.
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The Journal of Clinical Investigation Volume 52 January 1973 of the urine of similar patients we have found that they were dialysable, non-TCA precipitable, cationic, and that unlike iodopeptides they did not liberate iodotyrosines after conventional acid hydrolysis. They were not detected in the urine of normal men after the intravenous injection of either 3,5,3',5'-tetraiodo-L-thyronine (T4), 3,5,3'-triiodo-L-thyronine (T3), 3-monoiodo-L-tyrosine (MIT), or 3,5-diiodo-L-tyrosine (DIT). Moreover they were not unique to this variety of congenital goiter since they were detected in the urine of hyperthyroid and thyroid cancer patients treated by 'I. Free monoiodohistidine (MIH) and diiodohistidine (DIH) were identified in the BII moiety of the urine by the methods presented in the preceding paper (12) . Therefore the aims of the present study have been: (a) to identify and quantify the iodohistidines excreted in the urine of four patients suffering from this variety of congenital goitrous hypothyroidism; (b) to isolate and identify the iodoproteins from these goiters, with particular consideration given to the thyroglobulin (Tg) content; (c) to determine the iodohistidine and the thyroxine content of these iodoproteins; (d) to detect the presence or absence of an iodotyrosine deiodinase activity.
Evidence is presented here for the first time that: (a) MIH and DIH make up a large part of the BII fraction in the urine of this variety of congenital goiter patients; (b) the iodohistidine content of the iodoalbumin and of the minor unidentified iodoproteins produced by these goiters is similar, is higher than that of normal Tg, and is comparable with that of normal thyralbumin (Ta); (c) the true [127I] thyroxine content of the iodoalbumin produced by these congenital goiters is extremely low; (d) estimation of the iodoalbumin turnover in the congenital goiters affords a biochemical and metabolic understanding of this disease.
METHODS
Patients. Four patients with congenital goiters and a large urinary BII fraction were studied. Their main clinical and biological findings are summarized in Table I (21) ; immunodiffusion in agar against antiliuman-Tg precipitating sera (22) . In order to increase the sensitivity of the immunoidentification of the iodoproteins, portions of normal Tg and of the soluble protein fractions were in vitro 'I iodinated (23), sp act: 1040 uCi/mg. Immunoelectrophoreses in aiar (24) were then made.
The general methods applied to the isolation, the separation and the identification of the iodohistidines from the Pronase hydrolysates of the iodoproteins have been described in the preceding paper (12) . Briefly, the isolation was made by Dowex 1 chromatography; a partial purification was obtained by butanol partition; the separation of MIH and DIH from each other was obtained by Sephadex G-10 chromatography, and the identification relied upon crystallizations to a constant specific activity. The thyroxine content from the goiter iodoprotein hydrolysates was determined by competition analysis (25) . The 60%o vol/vol acetic acid Dowex 1 eluate of the Pronase hydrolysates was dried in a rotating vacuum evaporator. This fraction was dissolved in methanol-ammonia (1% vol/vol). The T4 assays (minimum sensitivity: 0.5 ng of T4) were considered as valid only when the experimental values from four dilutions were on a straight line extrapolating to zero.
Urines were analyzed for their iodohistidine content after a 4 N HCl acid hydrolysis at 60°C, for I h (12) .
Iodotyrosine deiodinase activity. Thin slices weighing 40-100 mg were incubated in 2.5 ml of 0.15 M Tris-HCl buffer (pH 7.4), in the presence of 10-s M labeled MIT and without the addition of NADPH. After incubating 30 min at 37°C, the I-produced was separated from MIT by Dowex 50 chromatography.
The enzyme was further characterized by determining from goiter homogenates the Km for MIT as previously described (12) . The iodotyrosine deiodinase peripheral activity was determined in vivo from labeled MIT or DIT in the conditions described (12) . The (15); BII from plasma by a modification of a described method (9) .
RESULTS
Identification of MIH and DIH in the urine of congenital goitrous patients. The iodide-free fraction of 24-h urine samples has been obtained by Dowex 1 chromatography. This fraction increased with time tip to a maximum of 40-71%, of the 24 h urine radioactivity on the 5th day (Fig. 1) . The size of this fraction was comparable from 127I and radioiodine determinations (Table II) . The iodocompounds constituting this fraction were not butanol-extractable and could be obtained by butanol partition with similar results. The activity prepared in either way was resolved into two peaks by Sephadex G-10 chromatography (Fig. 2) . When differently labeled MIH and/or DIH were added as internal indicators before the Sephadex G-10 chromatography, the first peak was superimposed with MIH and the second with DIH. The final identification was obtained by crystallizations to constant specific activity. The crystallizable MIH and DIH fractions obtained from the urines of three of the four patients are presented in Table II . In every urine sample analyzed, DIH was identified. The total crystallizable iodohistidine content was between 22 and 70% (mean 42%) of the iodide-free fraction of the urine radioactivity.
Iodotyrosine deiodinase activity. This was demonstrated in vitro in the two removed goiters and in vivo in all four cases. The MIT deiodination rate of goiter slices at MIT concentrations near the Vmax were estimated from the data obtained after Results in percent of given iodotyrosines recovered as such in the urine fractions. \6.
0.6 EM of normal human Tg; (b) Disc polyacrylamide gel electrophoresis from case 1 is shown in Fig. 3 The Dowex 1 purification of the Sepharose peak 2 (iodoalbumin) hydrolysate from case 1 is illustrated in Fig. 6 . The main result was the extraordinarily high "crude iodohistidine fraction :" 31.4% of the total '1I activity of the hydrolysate (corresponding fraction obtained from normal Tg: 1.94+0.54 SE [12] [1251]odoalbumin in 0.15M NaCI (ml) FIGURE 5 Identification by precipitin reaction of Sepharose peak 2 proteins from case 3. Increasing volumes of the in vivo-labeled protein solution, 1 mg/ml in 0.15 M NaCl, were allowed to react with a 0.2 ml constant volume of rabbit antihuman-albumin serum at 40C, 48 h. From the precipitates, twice washed with 0.15 M NaCl were obtained: the protein content, the radioactivities, and the precipitable radioactivities in percent of total radioactivity recovered in the immunoprecipitates.
Thyroglobulin Defect and Iodohistidine-Rich lodoalbumin Production respectively of the "25I iodoprotein radioactivities. The mean DIH/MIH ratio from case 1 was 1.16±0.07 SE (n = 6) and from case 3 was 0.35 (n = 2). From case 1, the 3 h newly incorporated 'I in iodohistidines was already in a proportion as high as two-thirds of the 7 day incorporated "I.
The mean DIT/MIT ratio from case 1 was 3.19 ±0.43 SE (n = 6), and 1.45±0.21 SE (n = 5) from case 3. There was no apparent correlation between the high DIT/MIT ratio or DIH/MIH ratio and the calculated iodination levels of the iodoproteins.
The thyroxine content of the separated protein fractions, presented in Table IV , was obtained by the specific competition analysis. The average T4 iodine was about 12 /Ag/g of protein from case 1 and 3.6 /Lg/g of protein from case 3. The very low To content of the iodoproteins is better demonstrated by the percent of the protein iodine identified as T4 iodine than by the conventional content per gram of protein if other uniodinated proteins are present as contaminants. T. iodine amounted to 1.2% of the "27I content of the predominant peak 2 iodoalbumin from case 1, and 3.6% from case 3.
Iodoalburnin turnover in the thyroid glands. This was estimated from simplified kinetics. They were derived from the findings that MIH is almost quantitatively recovered in urine after intravenous injection (12) . In addition the assumption was made that urinary MIH was a specific metabolite of iodoalbumin, disregarding the partial conversion of DIH to MIH and the proteolysis of other minor thyroidal iodoproteins. In case 1 it can be calculated from Table II that about 5 Ag of MIH iodine was excreted per day. MIH iodine in iodoalbumin amounts to 51 ,Ag/g (Table IV ). Therefore the iodoalbumin turnover in case 1 can be estimated to 100 mg/day and the T4-iodine secretion to 1 ,tg/day. Similar calculations indicate an iodoalbumin turnover in case 3 of 7 g/day with a T4-iodine secretion of 12 Ihg/day. Thus an over-stimulation of the thyroid gland may explain the latent or compensated hypothyroidism in case 3. Hypothyroidism is not always present in similar patients. Euthyroid and hypo- 
DISCUSSION
Mono-and diiodohistidine have been identified in the quantitatively large BII moiety of the urine from four patients with congenital goitrous hypothyroidism. Urinary iodohistidines were metabolites of thyroidal iodoproteins. Tg was absent, and the predominant protein identified in the two removed goiters was an iodoalbumin. This protein was found to be rich in iodohistidines as well as were the other unidentified protein fractions from the goiters. In contrast, their thyroxine contents were very low. Iodoalbumin turnover estimates were found to be very high but insufficient to maintain a normal thyroxine production.
The identification and the classification of congenital goitrous hypothyroidism has been mainly due to a penetrating analysis of the clinical and biological syndromes by Stanbury (27) . Five main varieties have been described in relation to the defective step of the thyroid hormonogenesis namely: the active transport of iodide, the organification of iodine, the iodotyrosine deiodination, the iodotyrosyl "coupling," and protein synthesis or breakdown.
This last variety or iodoprotein defect was first defined by the presence of BII compounds in the serum (1, 2) . The stable BII fraction of the serum may be high enough to raise the protein-bound iodine (PBJ) above normal values (28, 29) . In other reports, only the labeled BII moiety of the serum was elevated (2) and shown to contain peptide-linked iodotyrosines and iodothyronines (1).
In the four patients studied here, the PBI were low, and the PBI-T4 differences were not significant. A serum BII fraction was found in three cases. The latter analysis was not done in case 2 (brother of case 1 ). From the serum data only it is questionable whether the cases reported here could be included in the iodo-
Investigations of the thyroid itself give more conclusive evidence for the identification of this Tg defect. c Firstly, the high radioiodide uptake, the negative perchlorate discharge test, the detection of an iodotyrosine edeiodinase activity eliminate other syndromes except afor the rare occurrence of associated defects (3, 10) .
More important is the identification in the goiter extracts of an iodoalbumin (6) . This iodoalbumin has ialso been identified from the serum of the patients (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . From the poorly iodinated iodoalbumin, low peptide-linked levels of hormone were already reported (8, 11) . However the detection of iodoalbumin is not specific for this type of goiter. Iodoalbumin has been found rin normal animal and human thyroid glands (30, 31) and in a large variety of thyroid diseases (32) . The iodoprotein defect is better defined by the contrast between the presence of iodoalbumin and the absence of Tg. The possibility that the disease was a Tg defect has already been suggested (6) . False identification of the heavy iodoproteins collected in the Sepharose-peak 1 was avoided. Similar proteins were detected in congenital goiters from sheep (33) and cattle (34) .
In some reported cases, however, Tg was found only to be reduced (3) (4) (5) 7) . This might be due to incomplete protein identification, to incomplete forms of the disease or to the presence of a different disease. Evidence for the complete absence of Tg in our cases is strongly supported by the presented methods. Tg radioimmunoassay (35) with increased specificity and sensitivity might have demonstrated the presence of Tg traces. Tg defect means that the normal function of Tg as the support of normal hormonogenesis is completely missing. Tg structure has been shown to facilitate the thyroxine formation (36) . In addition Tg defect suggests a genetic origin. Examples of this congenital defect in siblings were reported (2, 3, 9, 37). Two of the reported four patients (cases 1 and 2) are siblings. A brother of case 3 suffers from the same disease.
The main findings of this study came from a completely different approach to the Tg defect. BII compounds, other than the circulating iodoalbumin, were often mentioned in this variety of congenital goiter as unidentified and puzzling substances. They were found after hydrolysis of the serum (1) or the thyroidal iodoproteins (7) as "resistant to digestion" material, remaining at the origin of the chromatograms (2) or insoluble in acid butanol (9) . They were detected in the urine of patients (8, 11) and presumed to be shortchain polypeptides (2), suggesting a iodoprotein breakdown defect. In the urine of the patients studied, a large part of these BII compounds was identified as iodohistidines. Evidence is presented in the preceding paper (12) that MIH and DIH are normally biosynthetized in thyroidal proteins, that Ta is richer in iodohistidines than Tg, and that iodohistidines, unaffected by iodotyrosine deiodinase, are excreted in urine. The high iodohistidine content of the iodoalbunmin produced by the congenital goiters studied is only comparable with that of normal Ta. Iodohistidine levels of in vitro-iodinated human serum albumin were found comparable with that of in vivo-iodinated albumin in preliminary experiments. The unidentified Sepharose-peak 1 heavy iodoproteins resembled iodoalbumin by their high iodohistidine anid low TI7 content. This is one more reason to differentiate this protein from Tg.
The recovery in the urine of large amounts of iodohistidines is directly related to a high iodoalbumin turnover in the goiters. Since iodohistidines have physicochemical properties which easily differentiate them from other iodinated molecules (12) it is suggested that simple methods such as ion-exchange chromatographies of the urine should be performed in every congenital goiter case, in an attempt to detect the Tg defect. The detection of iodohistidines in the urine rather than that of BII compounds in the serum may appear in the future to be a more specific and more constant parameter of the iodination of inappropriate proteins in the absence of Tg.
The question arises as to whether the loss of iodohistidine iodine in the urine could explain the hypothyroidism of the Tg defect patients. This loss is comparable with that of iodotyrosine iodine in the iodotyrosine-deiodinase defect (26) . However the high DIT/MIT ratio (3) as well as the observed high DIH/ MIH ratio in case 1 are strong arguments against the iodine-deficiency hypothesis. In contrast with the iodotyrosine-deiodinase defect (38) attempts to improve the thyroid hormonogenesis by supplementing the diet of the patients with iodine were unsuccessful. 10 mg of iodine per day for 8 mo to 5 yr before the operationgiven to case 1, and 2 mg of iodine per day for 2 mo to case 4 did not enhance the thyroid hormone secretion. Therefore iodine deficiency seems to play only an auxiliary role (if any) in this disease.
It can be concluded that the fundamental metabolic trouble in this disease, despite individual minor differences, is the genetic absence of Tg. The consequences are (a) the iodination of inappropriate proteins, mainly albumin, (b) a very low yield of thyroxine biosynthesis, (c) the formation of a goiter by a TSH oversecretion and a rapid thyroxine-poor iodoalbumin turnover, (d) a high production of iodohistidines by the proteolysis of the iodohistidine-rich iodoalbumin, (e) iodohistidines, not being deiodinated, are excreted in urine. The identification of iodohistidines in the urine may prove to be helpful in the detection of the Tg defect.
